Search - tctmd.com

Displaying 761 - 780 of 1502

Sort: Relevancy | Date

Presentation

Stent Thrombosis in New-Generation DES in Patients with STEMI Undergoing Primary PCI in SCAAR

Presenter: Giovanna Sarno

July 01, 2014

Presentation

Usefulness of Postmarket Studies to Evaluate Long-term Safety of Coronary Stents

Presenter: Moshe Vardi

June 11, 2014

Presentation

Trend in the Use of DES in the United States: Insight from Over 8.1 Million Coronary Interventions

Presenter: Sripal Bangalore

June 02, 2014

Presentation

Comparison of Biolimus A9-eluting (Nobori) and EES (Promus Element) in Long Coronary Lesions

Presenter: J.Y. Lee

May 29, 2014

Presentation EuroPCR 2014

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 22, 2014

Presentation EuroPCR 2014

Final Five Year Outcomes of the NOBORI2 Trial

Presenter: G.B. Danzi

May 22, 2014

Presentation EuroPCR 2014

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Presenter: Hiroyoshi Yokoi

May 21, 2014

Presentation EuroPCR 2014

BABILON TRIAL: A prospective randomized study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions

Presenter: Jos? Ram?n L?pez-M?nguez

May 20, 2014

Presentation EuroPCR 2014

Primary Results of the Multicenter COBRA Trial

Presenter: Christophe Dubois

May 20, 2014

Presentation

Meta-analysis of RCTs Comparing Short-term vs Long-term DAPT following DES

Presenter: G. El-Hayek

May 19, 2014

Presentation

Long-term (8-Year) Outcomes and Predictors of MACE After Full Metal Jacket (FMJ) DES Implantation

Presenter: C.W. Lee

April 30, 2014

Presentation

Randomized Trial of IN.PACT Admiral DCB vs PTA for Atherosclerotic Lesions in the SFA and/or PPA

Presenter: Gunnar Tepe

April 14, 2014

Presentation

Impact of Cardiac Rehab on Angiographic Outcomes after DES in Patients with Long Lesions

Presenter: J-Y. Lee

April 14, 2014

Presentation Fellows 2014

Stent Thrombosis and Restenosis

Presenter: Ajay Kirtane

April 13, 2014

Presentation Fellows 2014

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 12, 2014

Presentation

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Stenting

Presenter: Gilles Montalescot

April 11, 2014

Presentation ACC 2014

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 31, 2014

Presentation ACC 2014

The Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS)

Presenter: M. Valgimigli

March 31, 2014

Presentation PCI Outcomes 2014

BMS, DES, and BRS: A “Rational”Approach for Stent Selection

Presenter: Tullio Palmerini

March 28, 2014

Presentation PCI Outcomes 2014

The Thoughtful Approach to Recurrent DES Restenosis

Presenter: Robert A. Byrne

March 28, 2014

Advertisement

Stent Thrombosis in New-Generation DES in Patients with STEMI Undergoing Primary PCI in SCAAR

Usefulness of Postmarket Studies to Evaluate Long-term Safety of Coronary Stents

Trend in the Use of DES in the United States: Insight from Over 8.1 Million Coronary Interventions

Comparison of Biolimus A9-eluting (Nobori) and EES (Promus Element) in Long Coronary Lesions

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Final Five Year Outcomes of the NOBORI2 Trial

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

BABILON TRIAL: A prospective randomized study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions

Primary Results of the Multicenter COBRA Trial

Meta-analysis of RCTs Comparing Short-term vs Long-term DAPT following DES

Long-term (8-Year) Outcomes and Predictors of MACE After Full Metal Jacket (FMJ) DES Implantation

Randomized Trial of IN.PACT Admiral DCB vs PTA for Atherosclerotic Lesions in the SFA and/or PPA

Impact of Cardiac Rehab on Angiographic Outcomes after DES in Patients with Long Lesions

Stent Thrombosis and Restenosis

Drug-Eluting Stents: Past, Present, and Future

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Stenting

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

The Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS)

BMS, DES, and BRS: A “Rational”Approach for Stent Selection

The Thoughtful Approach to Recurrent DES Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content